Panag Pharma Announces Health Canada License for a Topical Cold-Sore Formulation NPN 80084806
Panag Pharma announces Health Canada approval for a topical Cold-Sore Formulation, a new generation topical formulation with a dual mechanism of action that improves healing rates and reduces symptoms.
May 9, 2018/by Panag RxPanag Pharma Inc. Announces Initiation Of A Clinical Trial
Panag Pharma, Inc. launched a clinical trial evaluating the use of the newly NHP registered product Topical AOTC, a new generation topical for pain and pain associated with inflammation.
May 3, 2018/by Panag Pharma Inc.Panag Pharma’s Dr. Melanie Kelly Interview On Global News Morning
Dr. Melanie Kelly weighs in on whether or not to keep medical and recreational marijuana separate.
July 28, 2017/by Panag Pharma Inc.Panag Pharma announces an Interview given by Dr. Melanie Kelly and Elizabeth Cairns on CBC supporting separate streams for Medical and Recreational Cannabis
Panag Pharma announces an Interview given by Dr. Melanie Kelly and Elizabeth Cairns on CBC supporting separate streams for Medical and Recreational Cannabis
July 18, 2017/by Panag Pharma Inc.Panag Pharma Announces Licensing Agreement With Tetra Bio Pharma
Panag Pharma announces licensing agreement with Tetra Bio Pharma
May 25, 2017/by Panag Pharma Inc.Panag Pharma Announces Patent Grant
Panag Pharma announces patent granted on novel formulation for treatment of ocular pain and inflammation
January 24, 2017/by Panag Pharma Inc.Panag Pharma Announces Launch Of A Regional Pilot Program
Panag Pharma announces the launch of a Regional Pilot Program to introduce Topical AOTC, a new generation pain and inflammation product.
January 11, 2017/by Panag Pharma Inc.Panag Pharma Announces Health Canada License For Topical A OTC (NPN 80070485)
Panag Pharma announces Health Canada approval for Topical A OTC, a new generation topical formulation with a dual mechanism of action against pain
June 21, 2016/by Panag Pharma Inc.News Articles By Month
News By Category
Latest Panag Pharma News
Site Search

Panag Pharma Inc.
Halifax, NS
Canada